Elmiron Lawsuit

Elmiron (Pentosan polysulfate) has been linked to a serious form of retinal disease that can cause vision loss such as macular degeneration and pattern dystrophy.

Elmiron’s manufacturers, Johnson & Johnson subsidiary Janssen Pharmaceuticals, knew that patients in the drug’s clinical trials were found to develop serious eye conditions like optic neuritis and retinal hemorrhage.

Yet Elmiron was released to the general public without any warnings about possible vision loss.

Elmiron IC drug

Free Case Evaluation

Elmiron Pigmentary Maculopathy
Elmiron Pigmentary Maculopathy

No further test were conducted until 2018, when Emory Eye Center shocked the medical community by saying that they found a link between a new form of pigmentary maculopathy and Elmiron. Since then, dozens of studies and a mountain of evidence has shown a strong connection between the painful bladder drug and serious eye damage.

In fact, the risk of pigmentary maculopathy was added to the Canadian version of the drug’s label in September 2019. U.S. consumers have been left in the dark — no such label is on American Elmiron.

The drug manufacturer may be obligated to provide compensation for your injuries and other damages to include: lost wages, medical expenses, loss of enjoyment of life, mental anguish, emotional distress, and others.

Frightening Reported Results

In 2019, Kaiser Permanente researchers conducted eye exams on 91 of their patients who had taken Elmiron for a minimum of 5 years. Out of those patients, 24% showed eye damage. The degree of eye damage increased with the quantity of Elmiron taken.

Also in 2019, the Emory Eye Center shared data from a national study of IC patients that included 1604 PPS (Elmiron) users. Of those 1604 patients, 53% were diagnosed with a retinal disease.

For some patients, retinal damage and vision loss has continued to worsen and degrade even after they stopped use of Elmiron years ago.

Those who have experienced vision loss after taking Elmiron may have a case against the drug’s manufacturer. We can help you pursue financial compensation, contact our legal team for a free consultation today.

What Should Those Who Took Elmiron Do?

Elmiron eye exam

First, contact an opthalmologist and talk to them about the possibility of vision loss. Those who are already experiencing vision loss should know that “Elmiron Maculopathy” may be misdiagnosed.

Loss of vision symptoms linked to Elmiron include:

  • Blurred vision
  • Difficulty adapting to low light
  • Difficulty reading
  • Dark spots
  • Straight lines appearing wavy
  • Muted color vision

The next step is to contact a lawyer. Our legal team is representing Elmiron patients in a case against the drug’s manufacturer. We can help those who are experiencing vision loss identify if it might be due to Elmiron — and pursue significant financial compensation if it is.

Elmiron Vision Loss Lawsuit

Do You Have an Elmiron Vision Loss Case? 

At Lerner and Rowe Injury Attorneys, our legal team encourages anyone who has been diagnosed with an eye disorder or vision problems after taking prescription Elmiron for over a year to contact our firm.

Call us directly at 844-977-1900chat with a live representative now, or share more details through an online form